Is MYND Life Sciences Inc halal to invest in?

According to Musaffa's Shariah screening methodology, MYND Life Sciences Inc (MYND.CN) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is MYND Life Sciences Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes MYND Life Sciences Inc using these criteria to determine its compliance status.

Can Muslims buy shares of MYND Life Sciences Inc?

Muslim investors may consider investing in MYND Life Sciences Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is MYND Life Sciences Inc classified as NOT COVERED?

Musaffa determines the Shariah status of MYND Life Sciences Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for MYND Life Sciences Inc updated?

The Shariah compliance status of MYND Life Sciences Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like MYND Life Sciences Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of MYND Life Sciences Inc?

You can check the latest Shariah compliance status of MYND Life Sciences Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

MYND Life Sciences Inc. Stock Analysis MYND.CN

Canada N/A Nano Cap

MYND Life Sciences, Inc. is a neuro-pharmaceutical drug development company. The firm is focused on neuro-pharmaceutical and novel psilocybin drug development, and diagnostics. The firm is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other (bio)pharmaceutical companies by molecular concepts for the applications of Psilocybins for overcoming disease. The firm is engaged in pharmaceutical developments through rigorous science and clinical trials while diligently patenting and safeguarding its intellectual property.

Key Statistics of MYND Life Sciences Inc (MYND.CN)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD0.03CAD0.07

Today's Open

CAD0.03

Volume

2000.00

P/E Ratio (TTM)

52 Week Range

CAD0.03CAD0.07

Market Cap

1.70M

Avg. Volume

18.50K

Dividend Yield

Financial Metrics & Statements of MYND Life Sciences Inc (MYND.CN)

FAQ's for MYND Life Sciences Inc (MYND.CN)

According to Musaffa’s Shariah screening methodology, MYND Life Sciences Inc (MYND.CN) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.